this looks promising....
also: check out this thread: http://www.socialanx...s-simple-83084/
this was mentioned in another thread, about safe and sustainable increase in dopamine, but i couldn't find any thread about this specific combo...
Posted 25 February 2010 - 10:25 PM
Posted 25 February 2010 - 10:48 PM
Edited by medievil, 25 February 2010 - 10:51 PM.
Posted 25 February 2010 - 10:57 PM
Hey,
Yeah this combo is definatly interesting, my name on social anxiety support is crazymed.
Memantine would be essential in this combo as it prevents downregulation of the D2 receptors, ive been thinking wheter to go with memantine+LDOPA or memantine+pramipexole.
Memantine also increases the enzyme that converts LDOPA/5HTP to Dopamine/Serotonin.
Posted 25 February 2010 - 11:01 PM
Yeah cardidopa is needed to block conversion of 5HTP/ldopa to serotonin/dopamine in the body wich causes a lot of side effects, it should unchanged get in the brain.Hey,
Yeah this combo is definatly interesting, my name on social anxiety support is crazymed.
Memantine would be essential in this combo as it prevents downregulation of the D2 receptors, ive been thinking wheter to go with memantine+LDOPA or memantine+pramipexole.
Memantine also increases the enzyme that converts LDOPA/5HTP to Dopamine/Serotonin.
there's a lot of mention to carbidopa in the thread... is it not needed in the combo when you have memantine?
speaking of social anxiety, any regimens you're using you find helpful?
Posted 26 February 2010 - 02:03 AM
Posted 26 February 2010 - 02:59 AM
If you guys are averse to using selegiline I would give the agonists a try before L-dopa.
Cabergoline seemed to work really well for me but the small chance of heart valve fibrosis is probably enough to rule it out as a long term therapy for a younger person. It's too soon for me to say how well the pramipexole is working but it seems promising so far.
Nicotine and catuaba are supposed to increase dopamine sensitivity. They've allowed me to avoid memantine for the time being.
Posted 26 February 2010 - 10:24 AM
Interesting, have you got a source regarding catuaba and dopamine sensitivity? I'm not going off memantine but it may be a good adjunct, nicotine didnt agree with me.If you guys are averse to using selegiline I would give the agonists a try before L-dopa.
Cabergoline seemed to work really well for me but the small chance of heart valve fibrosis is probably enough to rule it out as a long term therapy for a younger person. It's too soon for me to say how well the pramipexole is working but it seems promising so far.
Nicotine and catuaba are supposed to increase dopamine sensitivity. They've allowed me to avoid memantine for the time being.
Posted 26 February 2010 - 06:25 PM
which agonists would you recommend? pramipexole? why do you say agonists before L-dopa?
Unfortunately research into catuaba is lacking. The increased dopamine sensitivity is the theorized MOA for catuaba increasing libido. I can attest to its mood enhancing effects. I use the bark cuttings from MRH, trichilia catuaga, boiled/heated in water.Interesting, have you got a source regarding catuaba and dopamine sensitivity? I'm not going off memantine but it may be a good adjunct, nicotine didnt agree with me.
Posted 26 February 2010 - 06:40 PM
Unfortunately research into catuaba is lacking. The increased dopamine sensitivity is the theorized MOA for catuaba increasing libido. I can attest to its mood enhancing effects. I use the bark cuttings from MRH, trichilia catuaga, boiled/heated in water.
Posted 26 February 2010 - 07:27 PM
It made me feel horrible, after 2 days i was completely exhausted, maybe it went away after a few more days but i just felt to bad to contineu taking it (i used the patch and took it off at night).which agonists would you recommend? pramipexole? why do you say agonists before L-dopa?
The agonists don't cause oxidative damage when the body breaks them down as is the case with dopamine.Unfortunately research into catuaba is lacking. The increased dopamine sensitivity is the theorized MOA for catuaba increasing libido. I can attest to its mood enhancing effects. I use the bark cuttings from MRH, trichilia catuaga, boiled/heated in water.Interesting, have you got a source regarding catuaba and dopamine sensitivity? I'm not going off memantine but it may be a good adjunct, nicotine didnt agree with me.
What about nicotine didn't agree with you? I use the patches and probably only end up getting around ~4mg/day. Even at that it caused nausea at first. Fragmented sleep also. Both of those subsided after a week or two of consistent use, taking the patch off at night.
Edited by medievil, 26 February 2010 - 07:39 PM.
Posted 27 February 2010 - 03:09 AM
After searching through some articles it looks like you might be right.Are you sure about that? Can you link to any information? I thought catuaba acted as a reuptake inhibitor.
Posted 28 February 2010 - 05:43 PM
Neuroprotection by pramipexole against dopamine- and levodopa-induced cytotoxicity
Linglong Zou, Joseph Jankovic, Dominic B. Rowe, Wenjie Xie, Stanley H. Appel and Weidong Le
Department of Neurology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, U.S.A.
Revised 4 January 1999. Available online 20 May 1999.
Abstract
Pramipexole, a novel non-ergoline dopamine (DA) agonist, has been applied successfully for treatment of Parkinson's disease (PD). We report here that pramipexole can protect dopaminergic cell line Mes23.5 against dopamine- and levodopa-induced cytotoxicity possibly through a mechanism related to antioxidant activity. In the MES 23.5 cultures, DA and L-DOPA induce a dose- and time-dependent cytotoxicity, as determined by tetrazolium salt and trypan blue assays. Furthermore, an in situ terminal deoxynucleotidyl transferase assay demonstrates that DA-induced cell death is apoptotic. Pretreatment with pramipexole in a concentration range (4–100 μM) significantly attenuates DA- or L-DOPA-induced cytotoxicity and apoptosis, an action which is not blocked by D3 antagonist U-99194 A or D2 antagonist raclopride. Pramipexole also protects MES 23.5 cells from hydrogen peroxide-induced cytotoxicity in a dose-dependent manner. In cell-free system, pramipexole can effectively inhibit the formation of melanin, an end product resulting from DA or L-DOPA oxidation. These results indicate that pramipexole exerts its neuroprotective effect possibly through a mechanism, which is independent of DA receptors but related to antioxidation or scavenging of free radicals (e.g. hydrogen peroxide). As a direct DA agonist and potentially neuroprotective agent, pramipexole remains attractive in the treatment of PD.
Posted 28 February 2010 - 05:51 PM
Ive been looking into nicotine's upregulation of dopamine receptors and it only seems to be selective for the D3 receptors[1][2] NMDA antagonists upregulate D2 in the striatum and that is also very important.If you guys are averse to using selegiline I would give the agonists a try before L-dopa.
Cabergoline seemed to work really well for me but the small chance of heart valve fibrosis is probably enough to rule it out as a long term therapy for a younger person. It's too soon for me to say how well the pramipexole is working but it seems promising so far.
Nicotine and catuaba are supposed to increase dopamine sensitivity. They've allowed me to avoid memantine for the time being.
Posted 01 March 2010 - 12:12 AM
NVM, i missed that this study was done in vitro (allways get too excited and post before i readNeuroprotection by pramipexole against dopamine- and levodopa-induced cytotoxicity
Linglong Zou, Joseph Jankovic, Dominic B. Rowe, Wenjie Xie, Stanley H. Appel and Weidong Le
Department of Neurology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, U.S.A.
Revised 4 January 1999. Available online 20 May 1999.
Abstract
Pramipexole, a novel non-ergoline dopamine (DA) agonist, has been applied successfully for treatment of Parkinson's disease (PD). We report here that pramipexole can protect dopaminergic cell line Mes23.5 against dopamine- and levodopa-induced cytotoxicity possibly through a mechanism related to antioxidant activity. In the MES 23.5 cultures, DA and L-DOPA induce a dose- and time-dependent cytotoxicity, as determined by tetrazolium salt and trypan blue assays. Furthermore, an in situ terminal deoxynucleotidyl transferase assay demonstrates that DA-induced cell death is apoptotic. Pretreatment with pramipexole in a concentration range (4–100 μM) significantly attenuates DA- or L-DOPA-induced cytotoxicity and apoptosis, an action which is not blocked by D3 antagonist U-99194 A or D2 antagonist raclopride. Pramipexole also protects MES 23.5 cells from hydrogen peroxide-induced cytotoxicity in a dose-dependent manner. In cell-free system, pramipexole can effectively inhibit the formation of melanin, an end product resulting from DA or L-DOPA oxidation. These results indicate that pramipexole exerts its neuroprotective effect possibly through a mechanism, which is independent of DA receptors but related to antioxidation or scavenging of free radicals (e.g. hydrogen peroxide). As a direct DA agonist and potentially neuroprotective agent, pramipexole remains attractive in the treatment of PD.
It appears that pramipexole counteracts the neurotoxiticy of LDOPA, i think the combo of both in low doses could be very promosing! The LDOPA would also counteract the decreased dopaminergic neurotransmission by prami at the start of treatment (thus preventing the initial anhedonia and sedation).
Highly synergetic combo.
Edited by medievil, 01 March 2010 - 12:19 AM.
Posted 02 March 2010 - 06:44 PM
http://www.socialanx...levodopa-84210/when i take it sublingually it doesn't make me sleepy!
i have had a good response to levodopa.
my SA physical symptoms are corrected. head, hand... tremor are gone. excessive blinking and abnormal heart rate are corrected.
i also have better sex drive and motivation and also better social interactions.
it's recommended.
Posted 15 July 2012 - 09:45 PM
If you guys are averse to using selegiline I would give the agonists a try before L-dopa.
Cabergoline seemed to work really well for me but the small chance of heart valve fibrosis is probably enough to rule it out as a long term therapy for a younger person. It's too soon for me to say how well the pramipexole is working but it seems promising so far.
Nicotine and catuaba are supposed to increase dopamine sensitivity. They've allowed me to avoid memantine for the time being.
0 members, 1 guests, 0 anonymous users